| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |